Capecitabine and streptozocin ± cisplatin for gastroenteropancreatic neuroendocrine tumours: predictors of long-term survival in the NET01 trial
Huvudupphovsmän: | , , , , , , , , , , , , , , , , |
---|---|
Materialtyp: | Conference item |
Publicerad: |
Oxford University Press
2016
|